Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   


RGD uses the Human Disease Ontology (DO, for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Tumor Lysis Syndrome
go back to main search page
Accession:DOID:9003827 term browser browse the term
Definition:A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
Synonyms:exact_synonym: Tumor Lysis Syndromes;   Tumour Lysis Syndrome;   Tumour Lysis Syndromes
 primary_id: MESH:D015275
 xref: EFO:1001479
For additional species annotation, visit the Alliance of Genome Resources.

show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 20988
    syndrome 10788
      Tumor Lysis Syndrome 0
Path 2
Term Annotations click to browse term
  disease 20988
    disease of anatomical entity 18178
      Immune & Inflammatory Diseases 5897
        immune system disease 5108
          lymphatic system disease 1636
            lymphoproliferative syndrome 1025
              Tumor Lysis Syndrome 0
paths to the root